Argatroban Market size is forecast to reach 1.37 Billion by 2025, growing a CAGR of 3.25 during the forecast period 2020-2025.Argatroban is used with aspirin to treat and prevent harmful blood clots and it blocks certain natural substances that the body uses to form blood clots. Heparin is a more commonly used thrombin inhibitor, but it results in deficiency of blood platelet count in some cases and argatroban caters to this need by acting as a thrombin inhibitor without leading to any heparin like complications are the major factors driving the growth of the market. The characteristics of hepatic mechanism is increasing the use of argatroban in the patients with renal dysfunction and this tends to increase the overall market demand of argatroban during the forecast period 2020-2025.

Key Takeaways

North America dominates the Argatroban Market owing to its high consumption and increasing number of patients with heptatic impairment. The Argatroban Market scope for different regions will be provided in the final report.

Increase of thrombosis in individuals and heparin induced thrombocytopenia is likely to aid in the market growth of argatroban.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Argatroban Market report.

Low molecular weight and argatroban does not induce formation of antibodies that can alter its clearance and the high cost of argatroban is set to create hurdles for the Argatroban Market.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=501906

Geography – Segment Analysis

North America hold major share of 33.9% of total Argatroban Market followed by Asia Pacific. North America dominates the argatroban market owing to its high consumption among patients. Argatroban is metabolized in the liver and has a half-life of about 50 minutes. It is monitored by PTT. Owing to its hepatic metabolism, it is used in patients with renal dysfunction and this is increasing the demand of argatroban market in the North America region.

Drivers – Argatroban Market :

1. Increase of thrombosis in individuals and heparin induced thrombocytopenia
2. Argatroban as an anticoagulant in individuals

Argatroban Industry Outlook : Argatroban top 10 companies are Pfizer, GlaxoSmithKline, SANDOZ, Eagle Pharmaceuticals, Fresenius Kabi, Teva Pharmaceutical Industries, Mitsubishi Tanabe Pharma, and WEST-WARD, among others.

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.